https://brandequity.economictimes.indiatimes.com/news/business-of-brands/fda-to-weigh-easing-limits-on-unproven-peptides-favored-by-rfk-jr-and-other-maha-figures/130302004
FDA Considers Loosening Regulations on Popular Peptides Amid Controversy, ETBrandEquity
The FDA plans to review easing restrictions on unapproved peptide injections promoted by wellness influencers. These peptides, including BPC-157, are known for...
popular peptidesfdaconsiderslooseningregulations